PMV Pharmaceuticals
PMVP
PMVP
69 hedge funds and large institutions have $45.8M invested in PMV Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 16 increasing their positions, 20 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
1.02% less ownership
Funds ownership: 70.33% → 69.31% (-1%)
20% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 20
Holders
69
Holding in Top 10
2
Calls
$108K
Puts
–
Top Buyers
| 1 | +$2.99M | |
| 2 | +$2.37M | |
| 3 | +$1.5M | |
| 4 |
Morgan Stanley
New York
|
+$973K |
| 5 |
LP
Longaeva Partners
Chicago,
Illinois
|
+$702K |
Top Sellers
| 1 | -$6.22M | |
| 2 | -$884K | |
| 3 | -$563K | |
| 4 |
Jane Street
New York
|
-$476K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$438K |
